Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Smoot

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Annals of Surgical Oncology|October 3, 2025
Carcinoid Syndrome Impacts Long-Term Outcomes After Hepatectomy for Small Bowel Neuroendocrine Tumor Liver MetastasisMarkus Ammann, Hallbera Gudmundsdottir, Elizabeth B Habermann, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
Journal of Neuroendocrinology|February 13, 2025
Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumorsHallbera Gudmundsdottir, Rondell P Graham, Patricia T Greipp, et al.
Hepatology (Baltimore, Md.)|October 20, 2020
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic SurgeryPatrick Starlinger, David Pereyra, Hubert Hackl, et al.
Annals of Surgical Oncology|May 8, 2024
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive HepatectomyMarkus Ammann, Hallbera Gudmundsdottir, Hubert Hackl, et al.
Surgery|January 2, 2022
"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct culturesJennifer A Yonkus, Emma Whittle, Roberto Alva-Ruiz, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2024
Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasisMarkus Ammann, Stella K Adjei Antwi, Hallbera Gudmundsdottir, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Annals of Surgical Oncology|October 3, 2025
Carcinoid Syndrome Impacts Long-Term Outcomes After Hepatectomy for Small Bowel Neuroendocrine Tumor Liver MetastasisMarkus Ammann, Hallbera Gudmundsdottir, Elizabeth B Habermann, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
Journal of Neuroendocrinology|February 13, 2025
Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumorsHallbera Gudmundsdottir, Rondell P Graham, Patricia T Greipp, et al.
Hepatology (Baltimore, Md.)|October 20, 2020
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic SurgeryPatrick Starlinger, David Pereyra, Hubert Hackl, et al.
Annals of Surgical Oncology|May 8, 2024
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive HepatectomyMarkus Ammann, Hallbera Gudmundsdottir, Hubert Hackl, et al.
Surgery|January 2, 2022
"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct culturesJennifer A Yonkus, Emma Whittle, Roberto Alva-Ruiz, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2024
Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasisMarkus Ammann, Stella K Adjei Antwi, Hallbera Gudmundsdottir, et al.
Pageof 18